Synopsis
Synopsis
0
JDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aequamen
2. Betahistin Al
3. Betahistin Ratiopharm
4. Betahistin Stada
5. Betahistin-ratiopharm
6. Betahistine
7. Betahistine Biphar
8. Betahistine Dihydrobromide
9. Betahistine Hydrochloride
10. Betahistine Mesylate
11. Betahistine Methanesulfonate
12. Betahistine Methanesulphonate
13. Betaserc
14. Betavert
15. By Vertin
16. By-vertin
17. Dihydrobromide, Betahistine
18. Dihydrochloride, Betahistine
19. Extovyl
20. Fidium
21. Hydrochloride, Betahistine
22. Lectil
23. Melopat
24. Mersilon
25. Mesylate, Betahistine
26. Methanesulfonate, Betahistine
27. Methanesulphonate, Betahistine
28. Pt 9
29. Pt-9
30. Pt9
31. Ribrain
32. Serc
33. Vasomotal
34. Vertigon
1. 5579-84-0
2. Betahistine Hydrochloride
3. Betahistine 2hcl
4. Betahistine Hcl
5. Serc
6. Betaserc
7. Microser
8. Antivom
9. 2-pyridineethanamine, N-methyl-, Dihydrochloride
10. Betahistine (dihydrochloride)
11. Pt-9
12. 2-(2-(methylamino)ethyl)pyridine Dihydrochloride
13. Betahistine Hydrochloride [usan:usp]
14. Beta-histine Dihdrochloride
15. N-methyl-n-(2-pyridin-2-ylethyl)amine Dihydrochloride
16. 5579-84-0 (hcl)
17. 49k58smz7u
18. Methyl[2-(2-pyridyl)ethyl]amine Dihydrochloride
19. N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
20. Veserc
21. Mfcd00012813
22. N-methyl-2-(pyridin-2-yl)ethanamine Dihydrochloride
23. Nsc-757397
24. Methyl[2-(pyridin-2-yl)ethyl]amine Dihydrochloride
25. Novo-betahistine
26. Pt 9
27. Betahistine Hydrochloride [usan]
28. Einecs 226-966-5
29. Unii-49k58smz7u
30. Betahistine Dihcl
31. Betahistine Di Hcl
32. Serc (tn)
33. Beta-histine Dihydrochloride
34. N-methyl-2-pyridin-2-ylethanamine Dihydrochloride
35. Schembl60646
36. Spectrum1500670
37. Betahistine Hydrochloride ,(s)
38. Betahistine Hydrochloride (usp)
39. Chembl1446813
40. Hy-b0524a
41. Betahistine Dihydrochloride, 97%
42. Dtxsid10204355
43. Amy40800
44. Bcp13779
45. Ccg-40327
46. S3176
47. Akos015891507
48. Ks-5298
49. Nsc 757397
50. 2-(2-(methylamino)ethyl)pyridine 2hcl
51. Betahistine Dihydrochloride [mi]
52. Betahistine Hydrochloride [mart.]
53. Betahistine Hydrochloride [vandf]
54. Ncgc00095910-01
55. Betahistine Hydrochloride [usp-rs]
56. Betahistine Hydrochloride [who-dd]
57. Db-052800
58. Ft-0622911
59. Ft-0663076
60. Sw196969-3
61. En300-31560
62. 79b840
63. D03102
64. Betahistine Hydrochloride [usp Monograph]
65. A830811
66. Betahistine Dihydrochloride [ep Monograph]
67. N-methyl-2-(2-pyridinyl)ethanamine Dihydrochloride
68. N-methyl-2-(pyridin-2-yl)ethanaminedihydrochloride
69. N-methyl-2-pyridin-2-yl-ethanamine Dihydrochloride
70. Q27259291
71. Betahistine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
72. Betahistine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 209.11 g/mol |
---|---|
Molecular Formula | C8H14Cl2N2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 208.0534038 g/mol |
Monoisotopic Mass | 208.0534038 g/mol |
Topological Polar Surface Area | 24.9 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 83.3 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Histamine Agonists
Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Switzerland
Brand Name : Betahistin-Mepha 24
Dosage Form : Tabl
Dosage Strength : 24mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Betahistine-Mepha 16
Dosage Form : Tabl
Dosage Strength : 16mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Betaserc
Dosage Form : Tabl
Dosage Strength : 24mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Sincrover
Dosage Form :
Dosage Strength : 50 Cpr 8 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Betahistine
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Betahistine
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Vertiserc
Dosage Form :
Dosage Strength : 20 Cpr 16 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Betahistine Sandoz 16Mg 30 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 16 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Betahistine Bluefish 8Mg 60 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 8 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Betahistine Cinfa 8Mg 60 Tablets Efg
Dosage Form : Tablet
Dosage Strength : 8 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : AURO-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 16MG
Packaging :
Approval Date :
Application Number : 2449153
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : AURO-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 24MG
Packaging :
Approval Date :
Application Number : 2449161
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : M-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number : 2519682
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : M-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 16MG
Packaging :
Approval Date :
Application Number : 2519690
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : M-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 24MG
Packaging :
Approval Date :
Application Number : 2519704
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Generic DCP Ongoing
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 24MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic DCP Ongoing
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NRA-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging :
Approval Date :
Application Number : 2544911
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PMS-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 16MG
Packaging : 100 (4X25)
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PMS-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 24MG
Packaging : 100 TAB(4X25)
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PMS-BETAHISTINE
Dosage Form : TABLET
Dosage Strength : 16MG
Packaging : 100 (4X25)
Approval Date :
Application Number : 2330210
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Menivert 24mg Tablets
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Serc 24
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Vertin 24
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Revihist 24 mg
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Hidrist 16 mg Tablets
Dosage Form : TAB
Dosage Strength : 16mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Dahide 24 mg Tablets
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Trevigo 24 mg Tablets
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Betahistine 24 Unicorn
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zygovert
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Hidrist 24 mg Tablets
Dosage Form : TAB
Dosage Strength : 24mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Betahistine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Betahistine Dihydrochloride API Price utilized in the formulation of products. Betahistine Dihydrochloride API Price is not always fixed or binding as the Betahistine Dihydrochloride Price is obtained through a variety of data sources. The Betahistine Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aequamen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aequamen, including repackagers and relabelers. The FDA regulates Aequamen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aequamen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aequamen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aequamen supplier is an individual or a company that provides Aequamen active pharmaceutical ingredient (API) or Aequamen finished formulations upon request. The Aequamen suppliers may include Aequamen API manufacturers, exporters, distributors and traders.
click here to find a list of Aequamen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aequamen DMF (Drug Master File) is a document detailing the whole manufacturing process of Aequamen active pharmaceutical ingredient (API) in detail. Different forms of Aequamen DMFs exist exist since differing nations have different regulations, such as Aequamen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aequamen DMF submitted to regulatory agencies in the US is known as a USDMF. Aequamen USDMF includes data on Aequamen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aequamen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aequamen suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aequamen Drug Master File in Korea (Aequamen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aequamen. The MFDS reviews the Aequamen KDMF as part of the drug registration process and uses the information provided in the Aequamen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aequamen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aequamen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aequamen suppliers with KDMF on PharmaCompass.
A Aequamen CEP of the European Pharmacopoeia monograph is often referred to as a Aequamen Certificate of Suitability (COS). The purpose of a Aequamen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aequamen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aequamen to their clients by showing that a Aequamen CEP has been issued for it. The manufacturer submits a Aequamen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aequamen CEP holder for the record. Additionally, the data presented in the Aequamen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aequamen DMF.
A Aequamen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aequamen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aequamen suppliers with CEP (COS) on PharmaCompass.
A Aequamen written confirmation (Aequamen WC) is an official document issued by a regulatory agency to a Aequamen manufacturer, verifying that the manufacturing facility of a Aequamen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Aequamen APIs or Aequamen finished pharmaceutical products to another nation, regulatory agencies frequently require a Aequamen WC (written confirmation) as part of the regulatory process.
click here to find a list of Aequamen suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aequamen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aequamen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aequamen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aequamen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aequamen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aequamen suppliers with NDC on PharmaCompass.
Aequamen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aequamen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aequamen GMP manufacturer or Aequamen GMP API supplier for your needs.
A Aequamen CoA (Certificate of Analysis) is a formal document that attests to Aequamen's compliance with Aequamen specifications and serves as a tool for batch-level quality control.
Aequamen CoA mostly includes findings from lab analyses of a specific batch. For each Aequamen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aequamen may be tested according to a variety of international standards, such as European Pharmacopoeia (Aequamen EP), Aequamen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aequamen USP).